Tirzepatide works for weight loss by decreasing appetite and slowing the movement of food from the stomach into the small intestine, which may make patients feel full more quickly and for a longer period of time. In type 2 diabetes, tirzepatide decreases blood sugar levels by increasing insulin production and lowering the amount of sugar the liver makes.

Tirzepatide is given as an injection under the skin once a week. Tirzepatide is a GIP and GLP-1 receptor agonist.

When you order from the MedShift Store, you'll receive a confirmation with instructions on how to submit your 503B prescription to MedShift’s Compounding Pharmacy Partner.

Our Compounding Pharmacy Partner will verify the validity of the order received from the MedShift Store and the prescription received from the practice prior to submitting it for fulfillment.

Each Tirzepatide order comes with a digital dosing chart, making it simple to determine the correct dosage. This chart features clear conversions from milligrams (mg) to milliliters (ml) and displays the corresponding dosage in units on a standard syringe. This ensures accurate and efficient medication administration for each patient, empowering you to deliver optimal weight loss solutions within your practice.

The most common tirzepatide side effects include abdominal pain, burping, constipation, diarrhea, dyspepsia, fatigue, gastroesophageal reflux disease, hair loss, hypersensitivity reactions, injection site reactions, nausea, and vomiting, which affects 5% or more patients.